Ignite Creation Date:
2024-05-05 @ 11:24 AM
Last Modification Date:
2024-10-26 @ 9:06 AM
Study NCT ID:
NCT00028327
Status:
COMPLETED
Last Update Posted:
2011-03-02
First Post:
2001-12-20
Brief Title:
Potent Antiviral Therapy for Critically Ill HIV Infected Patients Admitted to Intensive Care
Sponsor:
National Institute of Allergy and Infectious Diseases NIAID
Organization:
National Institute of Allergy and Infectious Diseases NIAID
Conditions & Keywords Data
Conditions:
| Name |
|---|
| HIV Infections |
Keywords:
| Name | View |
|---|---|
| Sepsis | View |
| AIDS-Related Opportunistic Infections | View |
| Zidovudine | View |
| HIV Protease Inhibitors | View |
| CD4 Lymphocyte Count | View |
| Lamivudine | View |
| Pneumonia | View |
| Nelfinavir | View |
| Reverse Transcriptase Inhibitors | View |
| Antiretroviral Therapy Highly Active | View |
| Efavirenz | View |
| Intensive Care Units | View |